Literature DB >> 11273649

CD81 regulates neuron-induced astrocyte cell-cycle exit.

S Kelić1, S Levy, C Suarez, D E Weinstein.   

Abstract

Astrocytes respond to contact with neurons by cell-cycle arrest and complex process formation. In our effort to discover the molecular mechanisms that underlie this phenomenon we have identified a known tetraspanin, CD81, as a critical component of astrocyte responses to neuronal differentiation signals. Here we show that CD81 is expressed on the surface of the astrocyte and that its expression level can be modulated by contact with neurons. Further, using three separate antibodies, 2F7, Eat1, and Eat2, which recognize unique epitopes in the extracellular domains of the CD81 protein, we show that there is a unique domain, recognized by Eat1, that is required for astrocyte cell-cycle withdrawal in response to neurons. This is likely due to conformational changes in the CD81 molecule, as inclusion of 2F7 actually augments neuron-induced astrocyte growth arrest. The critical nature of CD81 in normal astrocyte-neuron biology was confirmed by using mice in which CD81 had been deleted by homologous recombination. Astrocytes null at the CD81 locus were blind to the proliferative arrest encoded on the neuronal cell surface. Taken together, these data strongly suggest that CD81 is a critical regulator of neuron-induced astrocytic differentiation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273649     DOI: 10.1006/mcne.2000.0955

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  20 in total

1.  Characterization of mice lacking the tetraspanin superfamily member CD151.

Authors:  Mark D Wright; Sean M Geary; Stephen Fitter; Gregory W Moseley; Lai-Man Lau; Kuo-Ching Sheng; Vasso Apostolopoulos; Edouard G Stanley; Denise E Jackson; Leonie K Ashman
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  Evolution of increased glia-neuron ratios in the human frontal cortex.

Authors:  Chet C Sherwood; Cheryl D Stimpson; Mary Ann Raghanti; Derek E Wildman; Monica Uddin; Lawrence I Grossman; Morris Goodman; John C Redmond; Christopher J Bonar; Joseph M Erwin; Patrick R Hof
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

3.  Male CD81 knockout genotype disrupts Mendelian distribution of offspring.

Authors:  Whitney J Mordica; Ryan J Gallagher; Jenna L Kennedy; Stephen K Chapes
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

4.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

5.  IgSF8: a developmentally and functionally regulated cell adhesion molecule in olfactory sensory neuron axons and synapses.

Authors:  Arundhati Ray; Helen B Treloar
Journal:  Mol Cell Neurosci       Date:  2012-06-09       Impact factor: 4.314

6.  Genomewide analysis of the Drosophila tetraspanins reveals a subset with similar function in the formation of the embryonic synapse.

Authors:  Lee G Fradkin; Jessica T Kamphorst; Aaron DiAntonio; Corey S Goodman; Jasprina N Noordermeer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

7.  Increased density of retinal pigment epithelium in cd81-/- mice.

Authors:  Bong K Song; Shoshana Levy; Eldon E Geisert
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

8.  Macrophage cell lines use CD81 in cell growth regulation.

Authors:  Whitney J Mordica; Keith M Woods; Rollie J Clem; A Lorena Passarelli; Stephen K Chapes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-30       Impact factor: 2.416

9.  Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.

Authors:  Tatiana V Kolesnikova; Alexander R Kazarov; Madeleine E Lemieux; Marc A Lafleur; Santosh Kesari; Andrew L Kung; Martin E Hemler
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

10.  Normal viability of Kai1/Cd82 deficient mice.

Authors:  John I Risinger; Mary Custer; Lionel Feigenbaum; R Mark Simpson; Shelley B Hoover; Joshua D Webster; Gadisetti V R Chandramouli; Lino Tessarollo; J Carl Barrett
Journal:  Mol Carcinog       Date:  2013-02-08       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.